Sitting Here in Limbo

Discussion in 'Cylex' started by Anonymous, Apr 1, 2011 at 1:35 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Waiting for my options to be worth something. $7M in sales - 2008 level - reduced indication - priceless. The agency listened. Great job to one and all!
     

  2. Anonymous

    Anonymous Guest

    Well they can't sell more because they reduced the force and what the heck do they need an MSL for. Oops that would be because the indication has been narrowed.
     
  3. Anonymous

    Anonymous Guest

    'reduced inducation' - please elaborate.
     
  4. Anonymous

    Anonymous Guest

    indicated only for transpant patients and not all suppressed patients. Nice going team
     
  5. Anonymous

    Anonymous Guest

    Even still, this more limited usage should create enough value for it to become used more widespread.

    Very curious as to what reason the Board of Directors think this didn't go as they had hoped. It had such great potential and never came together. Most of the original players are gone with one exception.

    Well, what's done is done. Dust to dust.
     
  6. Anonymous

    Anonymous Guest

    It is amazing that teh board tolerates the turnover on the sales side. No wonder clinicians are skeptical
     
  7. Anonymous

    Anonymous Guest

    Are sales still flatlined at $8m or so?